Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385330470> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W4385330470 endingPage "3792" @default.
- W4385330470 startingPage "3787" @default.
- W4385330470 abstract "Platinum-based drugs are the standard treatment for ovarian cancer, and platinum resistance is a major problem. A previous study has reported that the UBE2L6 expression is elevated in cisplatin-resistant cells, which in turn leads to cisplatin resistance by modulating the transcriptional expression of ABCB6. The present study aimed to investigate the expression of UBE2L6 and ABCB6 in ovarian carcinoma and to evaluate the association between these markers and platinum resistance.Ninety-two patients diagnosed with serous ovarian carcinoma (SOC) were enrolled in this study. Tissue samples were collected from these patients and analysed using immunohistochemistry to assess the expression of UBE2L6 and ABCB6.UBE2L6 and ABCB6 staining was positive in 41 (44.6%) and 46 (50.0%) cases, respectively. UBE2L6 expression was statistically significantly associated with International Federation of Gynecology and Obstetrics (FIGO) stage (p=0.008). Both UBE2L6 and ABCB6 were significantly associated with platinum sensitivity (p<0.001 and p<0.001). A positive correlation was observed between the expression levels of UBE2L6 and ABCB6 (r=0.673, p<0.001). Progression-free survival (PFS) was significantly longer in the UBE2L6 negative group than that in the positive group (median PFS, 31.4 vs. 11.1 months, p<0.01) and in the ABCB6 negative group than that in the positive group (median PFS, 29.6 vs. 12.2 months, p<0.01).UBE2L6 and ABCB6 expression is associated with the prognosis of SOC. UBE2L6 and ABCB6 may be potential biomarkers of platinum-resistant ovarian cancer." @default.
- W4385330470 created "2023-07-29" @default.
- W4385330470 creator A5000464830 @default.
- W4385330470 creator A5001616254 @default.
- W4385330470 creator A5002638004 @default.
- W4385330470 creator A5014931636 @default.
- W4385330470 creator A5031696571 @default.
- W4385330470 creator A5060970883 @default.
- W4385330470 creator A5067778369 @default.
- W4385330470 date "2023-07-26" @default.
- W4385330470 modified "2023-10-16" @default.
- W4385330470 title "Association of UBE2L6 and ABCB6 Expression With Platinum Resistance in Serous Ovarian Carcinoma" @default.
- W4385330470 doi "https://doi.org/10.21873/anticanres.16564" @default.
- W4385330470 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37500176" @default.
- W4385330470 hasPublicationYear "2023" @default.
- W4385330470 type Work @default.
- W4385330470 citedByCount "0" @default.
- W4385330470 crossrefType "journal-article" @default.
- W4385330470 hasAuthorship W4385330470A5000464830 @default.
- W4385330470 hasAuthorship W4385330470A5001616254 @default.
- W4385330470 hasAuthorship W4385330470A5002638004 @default.
- W4385330470 hasAuthorship W4385330470A5014931636 @default.
- W4385330470 hasAuthorship W4385330470A5031696571 @default.
- W4385330470 hasAuthorship W4385330470A5060970883 @default.
- W4385330470 hasAuthorship W4385330470A5067778369 @default.
- W4385330470 hasConcept C121608353 @default.
- W4385330470 hasConcept C126322002 @default.
- W4385330470 hasConcept C143998085 @default.
- W4385330470 hasConcept C150173356 @default.
- W4385330470 hasConcept C204232928 @default.
- W4385330470 hasConcept C2776694085 @default.
- W4385330470 hasConcept C2777632260 @default.
- W4385330470 hasConcept C2778239845 @default.
- W4385330470 hasConcept C2780427987 @default.
- W4385330470 hasConcept C3019054536 @default.
- W4385330470 hasConcept C502942594 @default.
- W4385330470 hasConcept C71924100 @default.
- W4385330470 hasConceptScore W4385330470C121608353 @default.
- W4385330470 hasConceptScore W4385330470C126322002 @default.
- W4385330470 hasConceptScore W4385330470C143998085 @default.
- W4385330470 hasConceptScore W4385330470C150173356 @default.
- W4385330470 hasConceptScore W4385330470C204232928 @default.
- W4385330470 hasConceptScore W4385330470C2776694085 @default.
- W4385330470 hasConceptScore W4385330470C2777632260 @default.
- W4385330470 hasConceptScore W4385330470C2778239845 @default.
- W4385330470 hasConceptScore W4385330470C2780427987 @default.
- W4385330470 hasConceptScore W4385330470C3019054536 @default.
- W4385330470 hasConceptScore W4385330470C502942594 @default.
- W4385330470 hasConceptScore W4385330470C71924100 @default.
- W4385330470 hasIssue "8" @default.
- W4385330470 hasLocation W43853304701 @default.
- W4385330470 hasLocation W43853304702 @default.
- W4385330470 hasOpenAccess W4385330470 @default.
- W4385330470 hasPrimaryLocation W43853304701 @default.
- W4385330470 hasRelatedWork W1853532732 @default.
- W4385330470 hasRelatedWork W1986151536 @default.
- W4385330470 hasRelatedWork W2019814960 @default.
- W4385330470 hasRelatedWork W2398330439 @default.
- W4385330470 hasRelatedWork W2805900528 @default.
- W4385330470 hasRelatedWork W3210326642 @default.
- W4385330470 hasRelatedWork W4243197346 @default.
- W4385330470 hasRelatedWork W4308057531 @default.
- W4385330470 hasRelatedWork W4327675405 @default.
- W4385330470 hasRelatedWork W4385380379 @default.
- W4385330470 hasVolume "43" @default.
- W4385330470 isParatext "false" @default.
- W4385330470 isRetracted "false" @default.
- W4385330470 workType "article" @default.